DE10019154A1 - Zellbindende Nukleinsäuremoleküle (Aptamere) - Google Patents
Zellbindende Nukleinsäuremoleküle (Aptamere)Info
- Publication number
- DE10019154A1 DE10019154A1 DE10019154A DE10019154A DE10019154A1 DE 10019154 A1 DE10019154 A1 DE 10019154A1 DE 10019154 A DE10019154 A DE 10019154A DE 10019154 A DE10019154 A DE 10019154A DE 10019154 A1 DE10019154 A1 DE 10019154A1
- Authority
- DE
- Germany
- Prior art keywords
- nucleic acid
- acid molecule
- acid molecules
- seq
- aptamers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10019154A DE10019154A1 (de) | 2000-04-18 | 2000-04-18 | Zellbindende Nukleinsäuremoleküle (Aptamere) |
| DE50113417T DE50113417D1 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
| PCT/EP2001/004340 WO2001079538A2 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
| JP2001577520A JP2004503214A (ja) | 2000-04-18 | 2001-04-17 | 細胞結合核酸分子(アプタマー) |
| EP01929568A EP1294938B1 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
| AT01929568T ATE382098T1 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10019154A DE10019154A1 (de) | 2000-04-18 | 2000-04-18 | Zellbindende Nukleinsäuremoleküle (Aptamere) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10019154A1 true DE10019154A1 (de) | 2001-10-31 |
Family
ID=7639154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10019154A Ceased DE10019154A1 (de) | 2000-04-18 | 2000-04-18 | Zellbindende Nukleinsäuremoleküle (Aptamere) |
| DE50113417T Expired - Fee Related DE50113417D1 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE50113417T Expired - Fee Related DE50113417D1 (de) | 2000-04-18 | 2001-04-17 | Zellbindende nukleinsäuremoleküle (aptamere) |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1294938B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004503214A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE382098T1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE10019154A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001079538A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004055153A3 (de) * | 2002-12-17 | 2005-05-12 | Univ Eberhard Karls | Mit die adhäsion von biologischem material vermittelnden substanzen beschichtete vorrichtungen |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010118235A1 (en) * | 2009-04-08 | 2010-10-14 | The Regents Of The University Of California | Dna-cell conjugates |
| KR101189790B1 (ko) * | 2009-06-01 | 2012-10-11 | 성균관대학교산학협력단 | 췌장암 세포 또는 조직에 특이적으로 결합할 수 있는 핵산 압타머 및 그 용도 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996034875A1 (en) * | 1995-05-03 | 1996-11-07 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| WO1999007724A1 (en) * | 1997-08-05 | 1999-02-18 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| WO1999027138A1 (en) * | 1997-11-21 | 1999-06-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
-
2000
- 2000-04-18 DE DE10019154A patent/DE10019154A1/de not_active Ceased
-
2001
- 2001-04-17 AT AT01929568T patent/ATE382098T1/de not_active IP Right Cessation
- 2001-04-17 WO PCT/EP2001/004340 patent/WO2001079538A2/de not_active Ceased
- 2001-04-17 DE DE50113417T patent/DE50113417D1/de not_active Expired - Fee Related
- 2001-04-17 EP EP01929568A patent/EP1294938B1/de not_active Expired - Lifetime
- 2001-04-17 JP JP2001577520A patent/JP2004503214A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996034875A1 (en) * | 1995-05-03 | 1996-11-07 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| US6013443A (en) * | 1995-05-03 | 2000-01-11 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue SELEX |
| WO1999007724A1 (en) * | 1997-08-05 | 1999-02-18 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
| WO1999027138A1 (en) * | 1997-11-21 | 1999-06-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
Non-Patent Citations (2)
| Title |
|---|
| Biochemistry 33 (1994) 10450-10456 * |
| Biochemistry 37 (1998) 6857-6863 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004055153A3 (de) * | 2002-12-17 | 2005-05-12 | Univ Eberhard Karls | Mit die adhäsion von biologischem material vermittelnden substanzen beschichtete vorrichtungen |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001079538A2 (de) | 2001-10-25 |
| ATE382098T1 (de) | 2008-01-15 |
| JP2004503214A (ja) | 2004-02-05 |
| WO2001079538A3 (de) | 2003-01-16 |
| EP1294938B1 (de) | 2007-12-26 |
| DE50113417D1 (de) | 2008-02-07 |
| EP1294938A2 (de) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0517024B1 (de) | Tetravalente bispezifische Rezeptoren, ihre Herstellung und Verwendung | |
| Borrell et al. | Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections | |
| DE69431285T2 (de) | Herstellungsmethode von markierten genen; transcripten und proteinen | |
| DE69432315T2 (de) | ANTISENSE NUKLEINSÄUREN ZUR VORBEUGUNG UND BEHANDLUNG VON BESCHWERDEN IN WELCHEN DIE EXPRIMIERUNG VON C-erbB-2 EINE ROLLE SPIELT | |
| Ouwenga et al. | Transcriptomic analysis of ribosome-bound mRNA in cortical neurites in vivo | |
| DE3855064T2 (de) | Selektive Amplifikation von Oligonukleotiden-Zielsequenzen | |
| DE69433816T2 (de) | Die bestimmung von nukleinsäuremutationen durch analyse des sputum | |
| DE69534802T2 (de) | Verfahren von in Neuriten lokalisierten mRNAs zur medizinischen Diagnose und Therapie | |
| DE69034197T2 (de) | Genomische Klonierung und Kartographie | |
| DE69838544T2 (de) | Isolierung von gewebespezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane | |
| EP1572027B1 (de) | Implantate beschichtet mit Aptameren, die die Adhäsion von endothelialen Vorläuferzellen vermitteln | |
| DE4225569C2 (de) | Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie | |
| EP1634603A1 (de) | Behandlung von transformierten oder infizierten biologischen Zellen | |
| DE19625191A1 (de) | Nierenkarzinom-spezifische T-Zellen | |
| WO2002079507A2 (de) | Verfahren zur spezifischen detektion, isolation und charakterisierung von zellen aus körperproben durch transfektion von nukleinsäurekonstrukten | |
| DE112006002652T5 (de) | Verfahren zur isothermen Amplifikation von Nukleinsäuren und Verfahren zum Nachweisen von Nukleinsäuren durch gleichzeitige isotherme Amplifikation von Nukleinsäuren und Signalsonde | |
| EP1294938B1 (de) | Zellbindende nukleinsäuremoleküle (aptamere) | |
| DE4428651C1 (de) | Verfahren zur Herstellung und Amplifikation von Nukleinsäuren | |
| EP2373813B1 (de) | Verfahren zum nachweis methicillin-resistenter staphylococcus aureus (mrsa)-stämme | |
| DE60013410T2 (de) | Verfahren zur analyse der genexpressions-frequenz | |
| DE69737327T2 (de) | Verfahren zur identifizierung von essentiellen genen für das wachstum eines organismus | |
| EP1162276A2 (de) | mRNA Moleküle zur Verwendung als Indikatoren für den Aktivierungs- und Funktionszustand von T-Lymphozyten | |
| DE102006026191A1 (de) | Vorrichtung und Substanz zur Isolierung von mesenchymalen Stammzellen (MSC) | |
| US20140369934A1 (en) | dsRNA/DNA Hybrid Genome Replication Intermediate Of Metakaryotic Stem Cells | |
| DE69112309T2 (de) | Verfahren zum Nukleinsäurenachweis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8131 | Rejection |